IM Cannabis Corp. (IMCC)
2.26
-0.09 (-3.83%)
At close: Jan 14, 2025, 3:26 PM
2.26
0.00%
After-hours Jan 14, 2025, 03:26 PM EST
undefined% (undefined)
| Bid | 2 |
| Market Cap | 6.97M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -4.01 |
| PE Ratio (ttm) | -0.56 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.9 |
| Volume | 11,524 |
| Avg. Volume (20D) | 94,806 |
| Open | 2.25 |
| Previous Close | 2.35 |
| Day's Range | 2.20 - 2.68 |
| 52-Week Range | 1.13 - 8.10 |
| Beta | undefined |
About IMCC
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel....
Sector Healthcare
IPO Date May 20, 2020
Employees 95
Stock Exchange NASDAQ
Ticker Symbol IMCC
Website https://www.imcannabis.com
Next Earnings Release
IM Cannabis Corp. is scheduled to release its earnings on Mar 27, 2025,
before market opens.
Analysts project revenue of $10.43M, reflecting a 32.66% YoY growth and earnings per share of -0.39, making a -63.89% decrease YoY.
Analysts project revenue of $10.43M, reflecting a 32.66% YoY growth and earnings per share of -0.39, making a -63.89% decrease YoY.
3 months ago ·
Source
+6.73%
Shares of cannabis stocks are trading higher follo...
Unlock content with
Pro Subscription
8 months ago ·
Source
+8.92%
Shares of cannabis stocks are trading higher after Biden said the Justice Department is taking the next steps to reclassify marijuana from Schedule I to Schedule III.
